A simple yet specific drug nanocarrier

​

Grant agreement ID: 893371

Breast cancer-associated mortality in the developing world is higher compared to high-income countries. This indicates that treatment does not reach financially deprived regions. To address this problem, the EU-funded TEMPER project proposes to develop polymeric drug nanocarriers that demonstrate higher targeting specificity and efficacy without the common side effects of conventional drugs. These nanocarriers will be highly versatile and able to be tailored to deliver any drug of choice, including antibiotics against infections, or to be used for diagnostic purposes. The simplicity and cost-effectiveness of the TEMPER drug delivery approach will ensure its applicability in developing countries.